Quantification of molecular interactions between ApoE, amyloid-beta (Aβ) and laminin: Relevance to accumulation of Aβ in Alzheimer's disease

被引:27
|
作者
Zekonyte, Jurgita [1 ]
Sakai, Kenji [2 ]
Nicoll, James A. R. [3 ]
Weller, Roy O. [3 ]
Carare, Roxana O. [3 ]
机构
[1] Univ Southampton, Fac Engn & Environm, Southampton SO9 5NH, Hants, England
[2] Kanazawa Univ Hosp, Dept Neurol, Kanazawa, Ishikawa, Japan
[3] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
基金
英国生物技术与生命科学研究理事会; 英国工程与自然科学研究理事会;
关键词
Apolipoprotein E; Perivascular clearance pathways; Laminin; Atomic force microscopy; Amyloid-beta; Cerebral amyloid angiopathy; Alzheimer's disease; ISOFORM-SPECIFIC BINDING; APOLIPOPROTEIN-E; FORCE SPECTROSCOPY; ANGIOPATHY; PROTEIN; BRAIN; ATTACHMENT; CLEARANCE; DRAINAGE; REMOVAL;
D O I
10.1016/j.bbadis.2015.08.025
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Accumulation of amyloid-beta (A beta) in plaques in the brain and in artery walls as cerebral amyloid angiopathy indicates a failure of elimination of A beta from the brain with age and Alzheimer's disease. A major pathway for elimination of A beta and other soluble metabolites from the brain is along basement membranes within the walls of cerebral arteries that represent the lymphatic drainage pathways for the brain. The motive force for the elimination of A beta along this perivascular pathway appears to be the contrary (reflection) wave that follows the arterial pulse wave. Following injection into brain parenchyma, A beta rapidly drains out of the brain along basement membranes in the walls of cerebral arteries; such drainage is impaired in apolipoprotein E epsilon 4 (ApoE4) mice. For drainage of A beta to occur in a direction contrary to the pulse wave, some form of attachment to basement membrane would be required to prevent reflux of A beta back into the brain during the passage of the subsequent pulse wave. In this study, we show first that apolipoprotein E co-localizes with A beta in basement membrane drainage pathways in the walls of arteries. Secondly, we show by Atomic Force Microscopy that attachment of ApoE4/A beta complexes to basement membrane laminin is significantly weaker than ApoE3/A beta complexes. These results suggest that perivascular elimination of ApoE4/A beta complexes would be less efficient than with other isoforms of apolipoprotein E, thus endowing a higher risk for Alzheimer's disease. Therapeutic correction for ApoE4/A beta/laminin interactions may increase the efficiency of elimination of A beta in the prevention of Alzheimer's disease. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock. (c) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 50 条
  • [41] Clinical Implications of Amyloid-Beta Accumulation in Occipital Lobes in Alzheimer's Continuum
    Hwang, Jihye
    Kim, Chan Mi
    Kim, Ji Eun
    Oh, Minyoung
    Oh, Jungsu S.
    Yoon, Young Wook
    Kim, Jae Seung
    Lee, Jae-Hong
    Roh, Jee Hoon
    BRAIN SCIENCES, 2021, 11 (09)
  • [42] Amyloid-beta immunotherapy: the hope for Alzheimer disease?
    Barrera-Ocampo, Alvaro
    Lopera, Francisco
    COLOMBIA MEDICA, 2016, 47 (04): : 203 - 212
  • [43] Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome
    Ichimata, Shojiro
    Martinez-Valbuena, Ivan
    Lee, Seojin
    Li, Jun
    Karakani, Ali M.
    Kovacs, Gabor G.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (14)
  • [44] Imaging of Amyloid-Beta Deposits in the Postmortem Retina in Alzheimer's Disease
    Campbell, M. C. W.
    Gowing, L. J. F.
    Choi, Y.
    Leonenko, Z.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [45] Clearance of amyloid-beta in Alzheimer's disease: progress, problems and perspectives
    Wang, Yan-Jiang
    Zhou, Hua-Dong
    Zhou, Xin-Fu
    DRUG DISCOVERY TODAY, 2006, 11 (19-20) : 931 - 938
  • [46] Clusterin in Alzheimer’s disease: a player in the biological behavior of amyloid-beta
    Xiang Li
    Yifei Ma
    Xu Wei
    Yanpeng Li
    Huijuan Wu
    Jianhua Zhuang
    Zhongxin Zhao
    Neuroscience Bulletin, 2014, 30 : 162 - 168
  • [47] Plasma Amyloid-Beta Levels in Korean Patients with Alzheimer's Disease
    Cho, Sun Young
    Kang, So Young
    Lee, Woo In
    CLINICAL LABORATORY, 2016, 62 (08) : 1591 - 1593
  • [48] Failure of elimination of amyloid-beta from the brain in Alzheimer's disease
    de Silva, Prasanna
    Carare, Roxana O.
    Weller, Roy O.
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2008, 12 (04) : 6 - 10
  • [49] Amyloid-beta protein related treatment strategies in Alzheimer's disease
    Dodel, R
    EUROPEAN PSYCHIATRY, 2004, 19 : 102S - 102S
  • [50] Amyloid-beta peptide and tau protein crosstalk in Alzheimer's disease
    Roda, Alejandro R.
    Serra-Mir, Gabriel
    Montoliu-Gaya, Laia
    Tiessler, Lidia
    Villegas, Sandra
    NEURAL REGENERATION RESEARCH, 2022, 17 (08) : 1666 - 1674